Medtronic wins FDA clearance for Affera Prism-2 cardiac mapping software

Bitget2026/09/30 13:06

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Medtronic won FDA clearance and CE Mark for its Affera Prism-2 Mapping Software for use in cardiac ablation procedures.
CE Mark also granted for the PulseSelect ProxBox Adapter with Proximity Indicator software, adding real-time tissue proximity feedback.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medtronic plc published the original content used to generate this news brief via PR Newswire (Ref. ID: CG59974) on September 30, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Medtronic wins FDA clearance for Affera Prism-2 cardiac mapping software

You may also like

Crypto prices